7.37% and 10.80% from the previous year. The sales were impacted by several economic factors as well as the enforcement of the business shutdown order. As a result, the sales growth in this quarter did
clarify operating performance of the Company for the yearly ending 31 December 2018 are as follows: change 2018 2017 increase (decrease) Sales 841.1 882.2 -4.7% Other income 29.9 27.7 7.9% Cost of sales
Consolidated Financial Results for The Year 2019 For the year ended December 31st, 2019 Consolidated Profit & Loss of Global Consumer Public Company Limited Unit: Million Baht Y 2019 Y 2018 Change %YoY Revenues
the year ended 31 December 2017 and 2016 are as follows; Unit: THB million Y2017 Y2016 % Change 1. Revenue from sales and contract work 21.4 87.7 -75.6% 1.1 Turnkey Total Solutions 21.4 87.7 -75.6% 2
of the market competition both of the competitor and the pricing, some project could not continue to extend the services. However, the Private sector’s customer has continued growth, both from new
administrative expenses are as follows: Q-O-Q Change Increase/(Decrease) Q3/2017 Q3/2018 Selling expenses 3.9 5.6 43.6% Mainly caused from the sale promotion expenses and advertising expenses increase
www.interpharma.co.th IP_OCS/011/2020 8th June 2020 Subject: Notify the Resolutions of the Board of Directors Meeting, Change of Objectives of Funds Usage, Acquisition of Assets, The Issuance of Debentures and Fix the
Financial and Operating Highlights * ไม่รวมต้นทุนค่าเสื่อมราคาและค่าตัดจ าหน่าย Operating highlight in Q4/2018 and 2018 Q4/17 Q3/18 Q4/18 Change +/(-) 2017 2018 Change +/(-) (THB million) QoQ YoY YoY
Inventory gains/(losses) 4Core Net Profit is Reported Net Profit less Inventory gains/(losses) one-time extraordinary items 5Operating Cash Flow is after change in net working capital and cash tax, before